Maintenance of the Synergistic Effects of Cord Blood Cells and Erythropoietin Combination Therapy After Additional Cord Blood Infusion in Children With Cerebral Palsy: 1-Year Open-Label Extension Study of Randomized Placebo-Controlled Trial
A one-year open-label extension study aimed to identify the persistent synergistic effects of allogeneic umbilical cord blood cells and erythropoietin in children with cerebral palsy for up to two years.